India  
NewsR.in
> >

North America will remain the Most Attractive Market for Vitamins and Derivative Over 2026

GlobeNewswire Saturday, 13 January 2018
Rockville, MD, Jan. 13, 2018 (GLOBE NEWSWIRE) -- According to a new report published by Fact.MR, the global vitamins and derivatives market is expected to surpass 165,000 tons by the end of 2026 in terms of volume. During the forecast period (2017-2026), the market is projected to exhibit a CAGR of 3.5% in term of value. Rising health awareness among consumers, increasing demand for healthy and functional food, expanding geriatric population are some of important factors likely to influence the global consumption of vitamins and derivatives during the review period. Moreover, increased demand for products with higher nutritional content is expected to reflect favorably on the market. In has been observed that, use of vitamin supplements has grown notably in the countries such as Brazil, China, Philippines and India, which has propelled the market further.

*Request For Sample Report-* https://www.factmr.com/connectus/sample?flag=S&rep_id=380

Sufficient intake of vitamins and derivatives is important for maintaining a healthy body and preventing diseases that occur primarily due to weakness or malnourishment.  Vitamins and derivatives are being added to a variety of food products owing to rapid consumer inclination towards product that are healthy. Also, changing lifestyle and emerging fast-food culture is making intake of dietary supplements essential to ensure balance diet. Growing importance of maintaining a healthy lifestyle is also driving the demand for vitamin supplements. Modern consumers want to lead a healthy and active life and thereby seek food products that can help them achieve their daily dietary goals.

Use of vitamins and derivatives is also increased in pharmaceutical products as they have the potentials of curing various metabolic syndrome diseases. Increased emphasis on towards preventive healthcare is fueling demand for value-added products. Vitamins and derivatives are available in the form of gummies and softgels, capsules, tablets, oral liquid, and powder.

*Browse Full Report with TOC-* https://www.factmr.com/report/380/vitamins-derivatives-market

*Key Insights from the Report Include: *

*1-* Based on target group, the adult women segment is expected to hold its dominant position over 2026. The segment currently represents for more than 51% revenue share of the global market and expected to exhibit a CAGR of 2.8% during the assessment period

*2-* Consumption of vitamins and derivatives is relatively higher among adult women. This is primarily owing to a greater need for nutrition in adult women. Moreover, women all over the world are becoming increasingly conscious about their health and wellbeing.

*3-* Among regions, North America is expected to dominate the global vitamins and derivatives market in 2018, and the trend is likely to continue throughout the forecast period.

*4-* On the basis of product type, the Vitamin B segment is expected to remain highly attractive in 2018 and beyond. Currently, the segment is command for over one-fourth revenue share of the global market and expected to reach a market valuation in excess of US$ 7,300 Mn by the 2026. Over the course the forecast period, the segment is anticipated to grow by US$ 297.7 Mn annually.

*5-* On the basis of end use industry, the food and beverage segment is likely to retain its top position over 2026. By the end of 2026, this segment is estimated to surpass a market valuation of US$ 6,900 Mn, reflecting an above-average CAGR.

*Global Market for Vitamins and Derivatives: Competition Tracking *

Fact.MR in its report has profiled key market players, which include Herbalife, ADM, Abott Laboratories, Glanbia, Pfizer, Lonza Group Ltd, Sanofi, BoehringerIngelheim Consumer Health Care, CSPC Pharmaceutical Group Limited, Adisseo France S.A.S, Amway, Glanbia PLC, DSM, GlaxoSmithKline, Bayer, Jubilant Life Sciences Limited, Atrium Innovations, Inc., Schiff Nutrition International, Inc, Fermenta Biotech Ltd., and Bactolac Pharmaceutical, Inc. 

*Request Discount on Report-* https://www.factmr.com/connectus/sample?flag=S&rep_id=380

*About Fact.MR*

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

CONTACT: Mr. Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 

You Might Like


Tweets about this


Other recent news in Press Releases

KT Joins Philippines's $1.8 Bln BROADBAND ProjectNOVAtime to Showcase new User Interface and Concierge Enhanced Scheduling (CES) at 2018 CALIFORNIA HR Conference
Seal SOFTWARE Named to Inc. 5000 List of America’s Fastest-Growing Private Companies for Second Consecutive YearSavoy Magazine Publisher L.P. Green, II Honors the Passing of ARETHA FRANKLIN

Recent related videos

How to Invest in U.S., China Technology Stocks [Video]How to Invest in U.S., China Technology Stocks

Aug.16 -- Oliver Pursche, chief market strategist at Bruderman Asset Management, talks about Chinese and U.S. technology stocks and exchange-trade funds. He speaks with Ramy Inocencio and Yvonne Man on..

Bloomberg Technology -

Labor Market Strong, But U.S. Homebuilding Slowing [Video]Labor Market Strong, But U.S. Homebuilding Slowing

Reuters reports U.S. homebuilding rebounded less than expected from a nine-month low in July. The figures suggest the housing market is likely to tread water for the rest of this year against the..

Wochit Business -

Yuan to Go Through 7 Per Dollar, Jefferies' Darby Says [Video]Yuan to Go Through 7 Per Dollar, Jefferies' Darby Says

Aug.15 -- Sean Darby, chief equity strategist in Hong Kong at Jefferies Inc., talks about the dollar, emerging-market stocks, and the Chinese yuan. He speaks with Ramy Inocencio and Yvonne Man on..

Bloomberg Global Business -

Last Year in the Bull Market? Here's How You Make Money [Video]Last Year in the Bull Market? Here's How You Make Money

In the last year of a bull market, may people start to pull money out and park it in safer investments, like cash. But the market tends to do well in that last year, says Alli McCartney, managing..

The Street -

Environmentally friendly: newsR is hosted on servers powered solely by renewable energy
© 2018 newsR / One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Terms & Conditions  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal  |  Privacy & Data Protection Policy
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter